Visionary Wealth Advisors Astrazeneca PLC Transaction History

Visionary Wealth Advisors

$1.47 Billion
Q2 2024

A detailed history of Visionary Wealth Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Visionary Wealth Advisors holds 4,126 shares of AZN stock, worth $320,260. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,126

Previous 4,126 -0.0%

Holding current value

$320,260

Previous $279,000 15.05%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $28,378 - $32,350	-465 Reduced 10.13%	4,126 $279,000
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $49,512 - $55,424	800 Added 21.1%	4,591 $309,000
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $6,711 - $7,277	-96 Reduced 2.47%	3,791 $271,000
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $1,010 - $1,145	16 Added 0.41%	3,887 $269,000
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $1,138 - $1,479	-21 Reduced 0.54%	3,871 $262,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $1,113 - $2,850	21 Added 0.54%	3,892 $213,000
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $7,111 - $8,536	-120 Reduced 3.01%	3,871 $256,000
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $215,593 - $254,745	3,991 New	3,991 $232,000
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $235,907 - $258,114	-4,246 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $73,888 - $91,834	-1,526 Reduced 26.44%	4,246 $254,000
Q1 2021 May 18, 2021	BUY	$47.16 - $54.44 $4,716 - $5,444	100 Added 1.76%	5,772 $287,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $275,205 - $329,089	5,672 New	5,672 $284,000
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $203,576 - $234,379	-3,836 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $165,331 - $212,169	3,836 New	3,836 $203,000

Others Institutions Holding AZN

# of Institutions

1,333

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Visionary Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Visionary Wealth Advisors with notifications on news.

Account

Visionary Wealth Advisors Astrazeneca PLC Transaction History